Adnexal mass
Information
- Disease name
- Adnexal mass
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04051502 | Active, not recruiting | ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study | August 5, 2019 | August 2024 | |
NCT01466049 | Completed | New Biomarkers Evaluating Ovarian Cancer | December 2011 | March 2014 | |
NCT02520115 | Completed | Phase 1 | Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer | August 2015 | November 2018 |
NCT03297112 | Completed | Early Phase 1 | Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery | August 1, 2017 | September 4, 2018 |
NCT00987649 | Completed | Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | October 2009 | September 2010 | |
NCT03593681 | Completed | Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | August 27, 2018 | February 14, 2020 | |
NCT03837327 | Completed | Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy | April 16, 2019 | January 22, 2024 | |
NCT04260334 | Completed | N/A | Preoperative Care In Ovarian Cancer Patients | November 11, 2019 | September 30, 2020 |
NCT06366997 | Completed | Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test | October 9, 2019 | May 5, 2023 | |
NCT05761275 | Not yet recruiting | N/A | Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach | January 1, 2024 | April 3, 2025 |
NCT05974618 | Recruiting | Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA) | June 5, 2023 | July 2026 | |
NCT05051722 | Recruiting | Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | August 3, 2021 | December 30, 2025 | |
NCT05461872 | Recruiting | Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES | August 12, 2022 | December 31, 2023 | |
NCT05815992 | Recruiting | Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score | September 1, 2021 | December 2024 | |
NCT05842629 | Recruiting | Improved Diagnosis of Ovarian Cancer | May 15, 2021 | December 2028 | |
NCT05017246 | Recruiting | Phase 2 | Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy | January 18, 2022 | June 30, 2025 |
NCT04668521 | Terminated | Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection | May 4, 2020 | December 15, 2023 | |
NCT04487405 | Terminated | A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants | June 25, 2020 | December 15, 2023 | |
NCT03485651 | Terminated | Natera Ovarian Cancer Detection Assay | December 14, 2017 | December 31, 2019 | |
NCT03442881 | Unknown status | The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses | February 2018 | December 2018 |